Entero Therapeutics raises $3M in private placement; appoints two new directors

GridAI Technologies Corp.

Gross proceeds of $3.0M from sale of pre-funded warrants and common warrants priced at $0.6149 per unit.
$1M paid at closing (Aug 11, 2025); remaining $2M due upon effectiveness of resale registration statement.
Pre-funded warrants exercisable at $0.00001; common warrants at $0.3649, expire 5 years after registration effective.
Geordan Pursglove and Jason Sawyer appointed to Board effective Aug 11, 2025; each receives $2,500/month cash retainer.
Net proceeds for general corporate purposes and working capital.

item 1.01 item 3.02 item 5.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.